Related references
Note: Only part of the references are listed.Integrating domain knowledge with statistical and data mining methods for high-density genomic SNP disease association analysis
Valentin Dinu et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2007)
Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma
Matthew W. Jenner et al.
BLOOD (2007)
Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival
Ji-Rong Long et al.
PHARMACOGENETICS AND GENOMICS (2007)
Ras as a therapeutic target in hematologic malignancies
Yesid Alvarado et al.
EXPERT OPINION ON EMERGING DRUGS (2007)
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
John D. Shaughnessy et al.
BLOOD (2007)
Ghrelin stimulates angiogenesis in human microvascular endothelial cells: Implications beyond GH release
Aihua Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling
Wee J. Chng et al.
CANCER RESEARCH (2007)
Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: Final results of phase III US intergroup trial S9321
B Barlogie et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Molecular pathogenesis and a consequent classification of multiple myeloma
PL Bergsagel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells
SW Kim et al.
BONE (2005)
Genetic influences on health - Does race matter?
M Bamshad
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
High-density single-nucleotide polymorphism maps of the human genome
RD Miller et al.
GENOMICS (2005)
Ghrelin directly regulates bone formation
N Fukushima et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
FESD: A functional element SNPs database in human
HJ Kang et al.
NUCLEIC ACIDS RESEARCH (2005)
Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis
N Yanamandra et al.
ONCOGENE (2004)
PromoLign: A database for upstream region analysis and SNPs
T Zhao et al.
HUMAN MUTATION (2004)
Finishing the euchromatic sequence of the human genome
FS Collins et al.
NATURE (2004)
IL-8-mediated cell migration in endothelial cells depends on cathepsin B activity and transactivation of the epidermal growth factor receptor
IU Schraufstatter et al.
JOURNAL OF IMMUNOLOGY (2003)
Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma
RK Dasgupta et al.
BLOOD (2003)
Human gene mutation database (HGMD®):: 2003 update
PD Stenson et al.
HUMAN MUTATION (2003)
Multiplexed genotyping with sequence-tagged molecular inversion probes
P Hardenbol et al.
NATURE BIOTECHNOLOGY (2003)
Downstream effectors of oncogenic ras in multiple myeloma cells
LP Hu et al.
BLOOD (2003)
Bone morphogenetic protein (BMP)-2 induces apoptosis in human myeloma cells
C Kawamura et al.
LEUKEMIA & LYMPHOMA (2002)
Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients
NE Kay et al.
BLOOD (2001)
Initial sequencing and analysis of the human genome
ES Lander et al.
NATURE (2001)
Share Paper
